Nasdaq soars nearly 3% as stocks rebound from correction, but S&P posts 4-week skid
Wall Street's major averages rebounded strongly on Friday, a day after stocks closed in correction territory as President ...
moneycontrol.com2y
Nasdaq Technical Analysis
Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...
Nasdaq, S&P, and Dow are mixed as retail inflation cools more than expected
Wall Street's major averages trade mixed on Wednesday as retail inflation slowed more than expected in February along with ...
Sagimet Biosciences Announces Clearance of IND for FASN Inhibitor TVB-3567, to be Developed for the Treatment of Acne
TVB-3567 is the Company’s second fatty acid synthase (FASN) inhibitor First-in-human Phase 1 trial initiation planned in 2025 ...
Nasdaq1mon
Allogene Therapeutics Secures U.S. FDA IND Clearance for ALLO-329, Advancing its Next-Generation Allogeneic CAR T into Autoimmune Diseases
Jan. 28, 2025 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical ... with autoimmune diseases. Today, with the FDA’s clearance of our IND, that vision has become a ...
Nasdaq20d
Kadimastem and iTolerance Successfully Complete Pre-IND Meeting with the FDA for its Type 1 Diabetes Treatment
NLS Pharmaceutics Ltd. (Nasdaq: NLSP”) (“NLS”) and ... based regenerative medicine company, announced today the result from the Type B pre-IND meeting held by Kadimastem and iTolerance ...
Dow, S&P, and Nasdaq trade lower as labor report comes in lower than expected
Early on and the S&P 500 500 (SP500) was -0.3%, the Nasdaq Composite (COMP:IND) was -0.4%, and the Dow (DJI) was -0.1%. The ...
Nasdaq, S&P, Dow futures rise on hopes for tariff-relief deal
Stock index futures climbed on Wednesday as Commerce Secretary Howard Lutnick stoked hopes for a tariff-relief deal. Tariffs are triggering volatility. Don’t wait for tomorrow’s headlines—get the ...
Karolinska Development's portfolio company PharmNovo receives positive FDA feedback prior to IND application for Phase 2a trial
Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that portfolio company PharmNovo received positive feedback regarding its most advanced drug candidate, PN6047, in a pre-IND meeting ...
Mustang Bio Regains Compliance with Nasdaq Capital Market Requirement
Mustang received formal notice from Nasdaq confirming that the Company has satisfied the minimum stockholders’ equity requirement as set forth in Nasdaq Listing Rule 5550 (b) (1). As previously ...